Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE study

BACKGROUND: Plasma amyloid-β (Aβ) may facilitate identification of individuals with brain amyloidosis. Gut microbial dysbiosis in Alzheimer’s disease (AD) is increasingly being recognized. However, knowledge about alterations of gut microbiota in preclinical AD, as well as whether the combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Can, Yang, Kun, He, Beiqi, Du, Wenying, Cai, Yanning, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843023/
https://www.ncbi.nlm.nih.gov/pubmed/35164860
http://dx.doi.org/10.1186/s13195-022-00977-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843023/
https://www.ncbi.nlm.nih.gov/pubmed/35164860
http://dx.doi.org/10.1186/s13195-022-00977-x

Ejemplares similares